FILING ANALYSIS · WEDNESDAY, OCTOBER 21
THERMO FISHER SCIENTIFIC INC. TMO — 8-K: Results of Operations and Financial Condition
positive
Thermo Fisher Scientific reported strong Q3 results with 9% revenue growth, 9% GAAP diluted EPS growth, and 15% adjusted EPS growth, driven by its proven growth strategy and PPI Business System, but the actual impact on the stock price will depend on how the market reacts to the earnings beat and the company's updated 2026 financial guidance.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →